KAT6A_HUMAN - dbPTM
KAT6A_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID KAT6A_HUMAN
UniProt AC Q92794
Protein Name Histone acetyltransferase KAT6A
Gene Name KAT6A
Organism Homo sapiens (Human).
Sequence Length 2004
Subcellular Localization Nucleus. Nucleus, nucleolus. Nucleus, nucleoplasm. Nucleus, PML body. Recruited into PML body after DNA damage.
Protein Description Histone acetyltransferase that acetylates lysine residues in histone H3 and histone H4 (in vitro). Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity. May act as a transcriptional coactivator for RUNX1 and RUNX2. Acetylates p53/TP53 at 'Lys-120' and 'Lys-382' and controls its transcriptional activity via association with PML..
Protein Sequence MVKLANPLYTEWILEAIKKVKKQKQRPSEERICNAVSSSHGLDRKTVLEQLELSVKDGTILKVSNKGLNSYKDPDNPGRIALPKPRNHGKLDNKQNVDWNKLIKRAVEGLAESGGSTLKSIERFLKGQKDVSALFGGSAASGFHQQLRLAIKRAIGHGRLLKDGPLYRLNTKATNVDGKESCESLSCLPPVSLLPHEKDKPVAEPIPICSFCLGTKEQNREKKPEELISCADCGNSGHPSCLKFSPELTVRVKALRWQCIECKTCSSCRDQGKNADNMLFCDSCDRGFHMECCDPPLTRMPKGMWICQICRPRKKGRKLLQKKAAQIKRRYTNPIGRPKNRLKKQNTVSKGPFSKVRTGPGRGRKRKITLSSQSASSSSEEGYLERIDGLDFCRDSNVSLKFNKKTKGLIDGLTKFFTPSPDGRKARGEVVDYSEQYRIRKRGNRKSSTSDWPTDNQDGWDGKQENEERLFGSQEIMTEKDMELFRDIQEQALQKVGVTGPPDPQVRCPSVIEFGKYEIHTWYSSPYPQEYSRLPKLYLCEFCLKYMKSRTILQQHMKKCGWFHPPANEIYRKNNISVFEVDGNVSTIYCQNLCLLAKLFLDHKTLYYDVEPFLFYVLTQNDVKGCHLVGYFSKEKHCQQKYNVSCIMILPQYQRKGYGRFLIDFSYLLSKREGQAGSPEKPLSDLGRLSYMAYWKSVILECLYHQNDKQISIKKLSKLTGICPQDITSTLHHLRMLDFRSDQFVIIRREKLIQDHMAKLQLNLRPVDVDPECLRWTPVIVSNSVVSEEEEEEAEEGENEEPQCQERELEISVGKSVSHENKEQDSYSVESEKKPEVMAPVSSTRLSKQVLPHDSLPANSQPSRRGRWGRKNRKTQERFGDKDSKLLLEETSSAPQEQYGECGEKSEATQEQYTESEEQLVASEEQPSQDGKPDLPKRRLSEGVEPWRGQLKKSPEALKCRLTEGSERLPRRYSEGDRAVLRGFSESSEEEEEPESPRSSSPPILTKPTLKRKKPFLHRRRRVRKRKHHNSSVVTETISETTEVLDEPFEDSDSERPMPRLEPTFEIDEEEEEEDENELFPREYFRRLSSQDVLRCQSSSKRKSKDEEEDEESDDADDTPILKPVSLLRKRDVKNSPLEPDTSTPLKKKKGWPKGKSRKPIHWKKRPGRKPGFKLSREIMPVSTQACVIEPIVSIPKAGRKPKIQESEETVEPKEDMPLPEERKEEEEMQAEAEEAEEGEEEDAASSEVPAASPADSSNSPETETKEPEVEEEEEKPRVSEEQRQSEEEQQELEEPEPEEEEDAAAETAQNDDHDADDEDDGHLESTKKKELEEQPTREDVKEEPGVQESFLDANMQKSREKIKDKEETELDSEEEQPSHDTSVVSEQMAGSEDDHEEDSHTKEELIELKEEEEIPHSELDLETVQAVQSLTQEESSEHEGAYQDCEETLAACQTLQSYTQADEDPQMSMVEDCHASEHNSPISSVQSHPSQSVRSVSSPNVPALESGYTQISPEQGSLSAPSMQNMETSPMMDVPSVSDHSQQVVDSGFSDLGSIESTTENYENPSSYDSTMGGSICGNSSSQSSCSYGGLSSSSSLTQSSCVVTQQMASMGSSCSMMQQSSVQPAANCSIKSPQSCVVERPPSNQQQQPPPPPPQQPQPPPPQPQPAPQPPPPQQQPQQQPQPQPQQPPPPPPPQQQPPLSQCSMNNSFTPAPMIMEIPESGSTGNISIYERIPGDFGAGSYSQPSATFSLAKLQQLTNTIMDPHAMPYSHSPAVTSYATSVSLSNTGLAQLAPSHPLAGTPQAQATMTPPPNLASTTMNLTSPLLQCNMSATNIGIPHTQRLQGQMPVKGHISIRSKSAPLPSAAAHQQQLYGRSPSAVAMQAGPRALAVQRGMNMGVNLMPTPAYNVNSMNMNTLNAMNSYRMTQPMMNSSYHSNPAYMNQTAQYPMQMQMGMMGSQAYTQQPMQPNPHGNMMYTGPSHHSYMNAAGVPKQSLNGPYMRR
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
28PhosphorylationKKQKQRPSEERICNA
HHHCCCCCHHHHHHH
55.0420068231
37PhosphorylationERICNAVSSSHGLDR
HHHHHHHHHCCCCCH
24.5820068231
38PhosphorylationRICNAVSSSHGLDRK
HHHHHHHHCCCCCHH
21.5420068231
39PhosphorylationICNAVSSSHGLDRKT
HHHHHHHCCCCCHHH
17.6720068231
94AcetylationNHGKLDNKQNVDWNK
CCCCCCCCCCCCHHH
42.8025953088
116PhosphorylationGLAESGGSTLKSIER
HHHHCCCHHHHHHHH
33.81-
117PhosphorylationLAESGGSTLKSIERF
HHHCCCHHHHHHHHH
41.29-
120PhosphorylationSGGSTLKSIERFLKG
CCCHHHHHHHHHHCC
32.5626437602
132PhosphorylationLKGQKDVSALFGGSA
HCCCCCHHHHHCCCH
29.41-
138PhosphorylationVSALFGGSAASGFHQ
HHHHHCCCHHCCHHH
22.50-
141PhosphorylationLFGGSAASGFHQQLR
HHCCCHHCCHHHHHH
41.53-
172AcetylationPLYRLNTKATNVDGK
CEEEECCCCCCCCCC
52.7425953088
216AcetylationCSFCLGTKEQNREKK
CCCCCCCHHHCCCCC
56.3526051181
245PhosphorylationHPSCLKFSPELTVRV
CHHHHCCCCHHHHHE
18.8421815630
332PhosphorylationAQIKRRYTNPIGRPK
HHHHHHHCCCCCCCC
32.4824719451
344AcetylationRPKNRLKKQNTVSKG
CCCHHCCCCCCCCCC
54.0625953088
347PhosphorylationNRLKKQNTVSKGPFS
HHCCCCCCCCCCCCC
24.54-
350AcetylationKKQNTVSKGPFSKVR
CCCCCCCCCCCCCCC
67.2919608861
355AcetylationVSKGPFSKVRTGPGR
CCCCCCCCCCCCCCC
35.7919608861
369PhosphorylationRGRKRKITLSSQSAS
CCCCEEEEECCCCCC
24.5023431171
371PhosphorylationRKRKITLSSQSASSS
CCEEEEECCCCCCCC
20.0622210691
374PhosphorylationKITLSSQSASSSSEE
EEEECCCCCCCCCCC
31.8722210691
376PhosphorylationTLSSQSASSSSEEGY
EECCCCCCCCCCCCC
35.6830576142
377PhosphorylationLSSQSASSSSEEGYL
ECCCCCCCCCCCCCH
37.2828985074
378PhosphorylationSSQSASSSSEEGYLE
CCCCCCCCCCCCCHH
38.9930576142
379PhosphorylationSQSASSSSEEGYLER
CCCCCCCCCCCCHHE
41.43-
383PhosphorylationSSSSEEGYLERIDGL
CCCCCCCCHHEECCC
14.52-
399PhosphorylationFCRDSNVSLKFNKKT
CCCCCCCEEEECCCC
30.0522210691
401AcetylationRDSNVSLKFNKKTKG
CCCCCEEEECCCCCC
39.1125953088
407AcetylationLKFNKKTKGLIDGLT
EEECCCCCCCCCHHH
61.6823236377
415AcetylationGLIDGLTKFFTPSPD
CCCCHHHHCCCCCCC
43.4519608861
415UbiquitinationGLIDGLTKFFTPSPD
CCCCHHHHCCCCCCC
43.4521890473
418PhosphorylationDGLTKFFTPSPDGRK
CHHHHCCCCCCCCCC
26.4530266825
420PhosphorylationLTKFFTPSPDGRKAR
HHHCCCCCCCCCCCC
32.3430266825
433PhosphorylationARGEVVDYSEQYRIR
CCCEECCHHHHHCCH
11.51-
434PhosphorylationRGEVVDYSEQYRIRK
CCEECCHHHHHCCHH
17.4828555341
437PhosphorylationVVDYSEQYRIRKRGN
ECCHHHHHCCHHCCC
12.17-
447PhosphorylationRKRGNRKSSTSDWPT
HHCCCCCCCCCCCCC
35.2925159151
448PhosphorylationKRGNRKSSTSDWPTD
HCCCCCCCCCCCCCC
34.6623401153
449PhosphorylationRGNRKSSTSDWPTDN
CCCCCCCCCCCCCCC
37.4823927012
450PhosphorylationGNRKSSTSDWPTDNQ
CCCCCCCCCCCCCCC
39.3623927012
454PhosphorylationSSTSDWPTDNQDGWD
CCCCCCCCCCCCCCC
43.2420068231
463AcetylationNQDGWDGKQENEERL
CCCCCCCCHHHHHHH
52.5523236377
463UbiquitinationNQDGWDGKQENEERL
CCCCCCCCHHHHHHH
52.55-
473PhosphorylationNEERLFGSQEIMTEK
HHHHHHCCHHHCCHH
19.8017525332
478PhosphorylationFGSQEIMTEKDMELF
HCCHHHCCHHHHHHH
45.6129255136
480UbiquitinationSQEIMTEKDMELFRD
CHHHCCHHHHHHHHH
53.89-
495AcetylationIQEQALQKVGVTGPP
HHHHHHHHHCCCCCC
41.6325953088
495UbiquitinationIQEQALQKVGVTGPP
HHHHHHHHHCCCCCC
41.63-
517PhosphorylationSVIEFGKYEIHTWYS
CEEEEECEEEEECCC
22.0923663014
521PhosphorylationFGKYEIHTWYSSPYP
EECEEEEECCCCCCC
31.5923663014
523PhosphorylationKYEIHTWYSSPYPQE
CEEEEECCCCCCCHH
10.6323663014
524PhosphorylationYEIHTWYSSPYPQEY
EEEEECCCCCCCHHH
19.1923663014
525PhosphorylationEIHTWYSSPYPQEYS
EEEECCCCCCCHHHC
16.8623663014
527PhosphorylationHTWYSSPYPQEYSRL
EECCCCCCCHHHCCC
21.3523663014
531PhosphorylationSSPYPQEYSRLPKLY
CCCCCHHHCCCCHHH
8.2123663014
532PhosphorylationSPYPQEYSRLPKLYL
CCCCHHHCCCCHHHH
26.9623663014
604AcetylationAKLFLDHKTLYYDVE
HHHHCCCCCEECCCH
39.63155401
619PhosphorylationPFLFYVLTQNDVKGC
HHHEEEECCCCCCCC
18.4530576142
641AcetylationKEKHCQQKYNVSCIM
CCCCHHHCCCEEEEE
16.9525953088
678PhosphorylationKREGQAGSPEKPLSD
HCCCCCCCCCCCHHH
32.6630266825
684PhosphorylationGSPEKPLSDLGRLSY
CCCCCCHHHHHHHHH
39.0430266825
777PhosphorylationDPECLRWTPVIVSNS
CHHHHCCCEEEEECC
10.9727251275
782PhosphorylationRWTPVIVSNSVVSEE
CCCEEEEECCCCCHH
16.5630576142
784PhosphorylationTPVIVSNSVVSEEEE
CEEEEECCCCCHHHH
19.1830266825
787PhosphorylationIVSNSVVSEEEEEEA
EEECCCCCHHHHHHH
36.8230266825
812PhosphorylationQERELEISVGKSVSH
HHHEEEEEECCCCCC
18.5530266825
815AcetylationELEISVGKSVSHENK
EEEEEECCCCCCCCC
45.5916916647
822AcetylationKSVSHENKEQDSYSV
CCCCCCCCCCCCCCC
54.4923236377
826PhosphorylationHENKEQDSYSVESEK
CCCCCCCCCCCCCCC
20.9921815630
827PhosphorylationENKEQDSYSVESEKK
CCCCCCCCCCCCCCC
25.6530576142
828PhosphorylationNKEQDSYSVESEKKP
CCCCCCCCCCCCCCC
24.3030576142
831PhosphorylationQDSYSVESEKKPEVM
CCCCCCCCCCCCCCC
53.1930576142
833AcetylationSYSVESEKKPEVMAP
CCCCCCCCCCCCCCC
80.8726051181
834AcetylationYSVESEKKPEVMAPV
CCCCCCCCCCCCCCC
42.2125953088
834SumoylationYSVESEKKPEVMAPV
CCCCCCCCCCCCCCC
42.2128112733
842PhosphorylationPEVMAPVSSTRLSKQ
CCCCCCCCCCCCCCC
25.5720068231
843PhosphorylationEVMAPVSSTRLSKQV
CCCCCCCCCCCCCCC
20.1320068231
844PhosphorylationVMAPVSSTRLSKQVL
CCCCCCCCCCCCCCC
28.2920068231
847PhosphorylationPVSSTRLSKQVLPHD
CCCCCCCCCCCCCCC
20.1127282143
848AcetylationVSSTRLSKQVLPHDS
CCCCCCCCCCCCCCC
49.3625953088
882AcetylationTQERFGDKDSKLLLE
HHHHHCCCCHHHHHH
65.3725953088
891PhosphorylationSKLLLEETSSAPQEQ
HHHHHHHCCCCCHHH
20.7125627689
892PhosphorylationKLLLEETSSAPQEQY
HHHHHHCCCCCHHHH
27.9925627689
893PhosphorylationLLLEETSSAPQEQYG
HHHHHCCCCCHHHHC
51.9225627689
899PhosphorylationSSAPQEQYGECGEKS
CCCCHHHHCCCCCCC
17.71-
905AcetylationQYGECGEKSEATQEQ
HHCCCCCCCHHHHHH
38.5926051181
909PhosphorylationCGEKSEATQEQYTES
CCCCCHHHHHHHCCC
28.7017525332
913PhosphorylationSEATQEQYTESEEQL
CHHHHHHHCCCHHHH
16.2430576142
914PhosphorylationEATQEQYTESEEQLV
HHHHHHHCCCHHHHH
32.5030576142
916PhosphorylationTQEQYTESEEQLVAS
HHHHHCCCHHHHHHC
38.3430576142
932AcetylationEQPSQDGKPDLPKRR
CCCCCCCCCCCCCCH
43.5823236377
941PhosphorylationDLPKRRLSEGVEPWR
CCCCCHHHCCCCCCC
30.4123401153
954PhosphorylationWRGQLKKSPEALKCR
CCCCCCCCHHHHHCC
26.7823401153
973PhosphorylationSERLPRRYSEGDRAV
CCCCCCCCCHHHHHH
16.6223312004
974PhosphorylationERLPRRYSEGDRAVL
CCCCCCCCHHHHHHH
33.0425159151
985PhosphorylationRAVLRGFSESSEEEE
HHHHHCCCCCCCCCC
39.1227732954
987PhosphorylationVLRGFSESSEEEEEP
HHHCCCCCCCCCCCC
41.6827732954
988PhosphorylationLRGFSESSEEEEEPE
HHCCCCCCCCCCCCC
45.0020873877
996PhosphorylationEEEEEPESPRSSSPP
CCCCCCCCCCCCCCC
36.0120873877
999PhosphorylationEEPESPRSSSPPILT
CCCCCCCCCCCCCCC
38.2530266825
1000PhosphorylationEPESPRSSSPPILTK
CCCCCCCCCCCCCCC
48.4130266825
1001PhosphorylationPESPRSSSPPILTKP
CCCCCCCCCCCCCCC
35.6223401153
1006PhosphorylationSSSPPILTKPTLKRK
CCCCCCCCCCCCCCC
35.3830266825
1007AcetylationSSPPILTKPTLKRKK
CCCCCCCCCCCCCCC
32.3419608861
1009PhosphorylationPPILTKPTLKRKKPF
CCCCCCCCCCCCCCC
46.6023927012
1014AcetylationKPTLKRKKPFLHRRR
CCCCCCCCCCHHHHH
45.0623749302
1041PhosphorylationVTETISETTEVLDEP
CEEECCCHHCCCCCC
22.8226074081
1042PhosphorylationTETISETTEVLDEPF
EEECCCHHCCCCCCC
21.7526074081
1052PhosphorylationLDEPFEDSDSERPMP
CCCCCCCCCCCCCCC
35.5229116813
1054PhosphorylationEPFEDSDSERPMPRL
CCCCCCCCCCCCCCC
39.1830576142
1064PhosphorylationPMPRLEPTFEIDEEE
CCCCCCCCEECCHHH
25.2326074081
1089PhosphorylationREYFRRLSSQDVLRC
HHHHHHHCHHHHHHC
24.9223401153
1090PhosphorylationEYFRRLSSQDVLRCQ
HHHHHHCHHHHHHCC
34.6830266825
1104PhosphorylationQSSSKRKSKDEEEDE
CCCCCCCCCCHHHHC
49.7423927012
1113PhosphorylationDEEEDEESDDADDTP
CHHHHCCCCCCCCCC
38.4523927012
1119PhosphorylationESDDADDTPILKPVS
CCCCCCCCCCCCHHH
16.8723403867
1126PhosphorylationTPILKPVSLLRKRDV
CCCCCHHHHHCCCCC
30.1623403867
1136PhosphorylationRKRDVKNSPLEPDTS
CCCCCCCCCCCCCCC
25.7430266825
1142PhosphorylationNSPLEPDTSTPLKKK
CCCCCCCCCCCCCCC
45.2630266825
1143PhosphorylationSPLEPDTSTPLKKKK
CCCCCCCCCCCCCCC
35.0930266825
1144PhosphorylationPLEPDTSTPLKKKKG
CCCCCCCCCCCCCCC
34.4323401153
1147AcetylationPDTSTPLKKKKGWPK
CCCCCCCCCCCCCCC
64.8426051181
1147MethylationPDTSTPLKKKKGWPK
CCCCCCCCCCCCCCC
64.84115973607
1148AcetylationDTSTPLKKKKGWPKG
CCCCCCCCCCCCCCC
68.3626051181
1148MethylationDTSTPLKKKKGWPKG
CCCCCCCCCCCCCCC
68.36115973615
1174AcetylationPGRKPGFKLSREIMP
CCCCCCCCCCCEECC
52.0125953088
1174MethylationPGRKPGFKLSREIMP
CCCCCCCCCCCEECC
52.01115973623
1330"N6,N6-dimethyllysine"HLESTKKKELEEQPT
CCHHHCHHHHHCCCC
69.92-
1330MethylationHLESTKKKELEEQPT
CCHHHCHHHHHCCCC
69.9223644510
1342SumoylationQPTREDVKEEPGVQE
CCCHHHHHHCCCCCH
69.5528112733
1350PhosphorylationEEPGVQESFLDANMQ
HCCCCCHHHHHHHHH
17.6428555341
1369PhosphorylationKIKDKEETELDSEEE
HHCCHHHHCCCCCCC
42.8322210691
1373PhosphorylationKEETELDSEEEQPSH
HHHHCCCCCCCCCCC
60.5825849741
1379PhosphorylationDSEEEQPSHDTSVVS
CCCCCCCCCCHHHHH
33.4222210691
1382PhosphorylationEEQPSHDTSVVSEQM
CCCCCCCHHHHHHHH
20.2824043423
1383PhosphorylationEQPSHDTSVVSEQMA
CCCCCCHHHHHHHHC
26.9524043423
1386PhosphorylationSHDTSVVSEQMAGSE
CCCHHHHHHHHCCCC
21.6922210691
1392PhosphorylationVSEQMAGSEDDHEED
HHHHHCCCCCCCCCC
28.4525849741
1400PhosphorylationEDDHEEDSHTKEELI
CCCCCCCCCCHHHHH
36.0124043423
1402PhosphorylationDHEEDSHTKEELIEL
CCCCCCCCHHHHHHH
44.0724043423
1436PhosphorylationQSLTQEESSEHEGAY
HHHCHHHHCCCCCHH
40.0326074081
1437PhosphorylationSLTQEESSEHEGAYQ
HHCHHHHCCCCCHHH
46.3726074081
1732PhosphorylationSTGNISIYERIPGDF
CCCCCEEEECCCCCC
7.74-
1772O-linked_GlycosylationDPHAMPYSHSPAVTS
CCCCCCCCCCCCCHH
16.1829351928
1774O-linked_GlycosylationHAMPYSHSPAVTSYA
CCCCCCCCCCCHHCC
14.4929351928
1778O-linked_GlycosylationYSHSPAVTSYATSVS
CCCCCCCHHCCEEEE
20.3729351928
1779O-linked_GlycosylationSHSPAVTSYATSVSL
CCCCCCHHCCEEEEC
13.2329351928
1856PhosphorylationMPVKGHISIRSKSAP
CCCCCEEEEEECCCC
13.2824719451
1859PhosphorylationKGHISIRSKSAPLPS
CCEEEEEECCCCCCC
29.3228857561
1861PhosphorylationHISIRSKSAPLPSAA
EEEEEECCCCCCCHH
36.0423401153
1866PhosphorylationSKSAPLPSAAAHQQQ
ECCCCCCCHHHHHHH
37.9227732954
1875PhosphorylationAAHQQQLYGRSPSAV
HHHHHHHHCCCHHHH
13.2223312004
1877MethylationHQQQLYGRSPSAVAM
HHHHHHCCCHHHHHH
31.66115484279
1889DimethylationVAMQAGPRALAVQRG
HHHHCCHHHHHHHCC
41.12-
1889MethylationVAMQAGPRALAVQRG
HHHHCCHHHHHHHCC
41.1230762639
2003MethylationSLNGPYMRR------
HCCCCCCCC------
35.00115484263
2004MethylationLNGPYMRR-------
CCCCCCCC-------
34.07115484271

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
369TPhosphorylationKinaseAKT1P31749
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
369TAcetylation

23431171
369TPhosphorylation

23431171
604KAcetylation



Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of KAT6A_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
BRPF1_HUMANBRPF1physical
19001415
HSP74_HUMANHSPA4physical
19001415
P53_HUMANTP53physical
19001415
EP300_HUMANEP300physical
19001415
ING5_HUMANING5physical
18794358
EAF6_HUMANMEAF6physical
18794358
BRPF1_HUMANBRPF1physical
18794358
H31_HUMANHIST1H3Aphysical
11742995
RUNX1_HUMANRUNX1physical
11742995
CBP_HUMANCREBBPphysical
15657427
ESR1_HUMANESR1physical
17697320
KMT2A_HUMANKMT2Aphysical
20581860
WDR5_HUMANWDR5physical
20581860
H3C_HUMANH3F3Cphysical
17925393
H4_HUMANHIST1H4Iphysical
17925393
H31T_HUMANHIST3H3physical
23063713
H31T_HUMANHIST3H3physical
22713874
PML_HUMANPMLphysical
23431171
P53_HUMANTP53physical
23431171
SYMPK_HUMANSYMPKphysical
23994619
KMT2A_HUMANKMT2Aphysical
23994619
H31T_HUMANHIST3H3physical
23431171
PHF14_HUMANPHF14physical
26496610
TNR6B_HUMANTNRC6Bphysical
26496610
PLPL8_HUMANPNPLA8physical
26496610
RSF1_HUMANRSF1physical
26496610
ING5_HUMANING5physical
26496610
H31_HUMANHIST1H3Aphysical
27775714

Drug and Disease Associations
Kegg Disease
OMIM Disease
Note=Chromosomal aberrations involving KAT6A may be a cause of acute myeloid leukemias. Translocation t(8
16)(p11
p13) with CREBBP
translocation t(8
22)(p11
q13) with EP300. KAT6A-CREBBP may induce leukemia by inhibiting RUNX1-mediated transcription. Inversion inv(8)(p11
q13) generates the KAT6A-NCOA2 oncogene, which consists of the N-terminal part of KAT6A and the C-terminal part of NCOA2/TIF2. KAT6A-NCOA2 binds to CREBBP and disrupts its function in transcription activation.
616268
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of KAT6A_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-350; LYS-355; LYS-604 ANDLYS-1007, AND MASS SPECTROMETRY.
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey.";
Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.;
Mol. Cell 23:607-618(2006).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-815, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1113, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-418; SER-420 ANDSER-1113, AND MASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-941, AND MASSSPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-473 AND THR-909, ANDMASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1113, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-449, AND MASSSPECTROMETRY.

TOP